Scheme 1From: Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s diseasePreparation of the precursor ligand, parental unlabeled ligand (7A), and its no-carrier-added counterpart ([ 18 F]-7B).Back to article page